On February 26, 2020, South America was hit by novel COVID-19 pneumonia on this day, ending its situation of zero confirmed cases. One Brazilian returning from Italy showed the positive test result of virus detection. Since then, novel COVID-19 pneumonia spread rapidly in South America. Jusha Medical high resolution display devices have been put into use widely to assist the medical institutions in South America for medical diagnosis.

On February 26, WHO pointed out that, South America was hit by novel COVID-19 pneumonia on this day, ending its situation of zero confirmed cases. One Brazilian returning from Italy showed the positive test result of virus detection. Due to the spread of novel COVID-19 pneumonia epidemic in South America, according to the CCTV news report, there have been 6836 confirmed cases of novel COVID-19 pneumonia in Brazil as of the local time 2 p.m., April 1, 2020, with newly added 1119 cases than the last day. The total death cases in the whole country of Brazil were up to 241. In Sao Paulo State, at present there are 2981 newly confirmed cases in all, accounting for 43% of the totally national confirmed cases. Due to the shortage of virus detection reagent, only the hospitalized patients and medical staff can be detected for priority.

According to the Brazilian national TV station report, presently one of the largest public hospitals in South America, the affiliated hospital of Faculty of Medicine, Universidade de São Paulo,USP, is utilizing professional Jusha Medical high resolution display system and AI picture processing for rapid diagnosis of novel COVID-19 pneumonia. Jusha Medical is an enterprise famous for engaging in high-tech product R&D and production, boasting with over 800 domestic and international patents and possessing the professional medical diagnosis display system mostly welcomed by the global medical workers. Jusha Medical professional high resolution display system is characterized by very high resolution, high brightness, 16 bit gray scale (65536 grades) and built-in DICOM-standard LUT, applicable to the demanding clinical diagnostic application, such as radiation systems of PACS, CT and DR. Presently, the professional Jusha Medical high resolution display system is being used by the affiliated hospital of Faculty of Medicine, Universidade de São Paulo, USP for the early-stage screening, detection and diagnosis of novel COVID-19 pneumonia. Moreover, it can be used for prognosis of review.

In Sao Paulo State, at present there are 2981 newly confirmed cases in all, accounting for 43% of the totally national confirmed cases. Due to the shortage of virus detection reagent at the early stage, only the hospitalized patients and medical staff can be detected for priority. Saint Paul City, the capital of Sao Paulo State, witnesses the COVID-19 infection cases of a large number of medical workers, also including subsidiary workers in hospitals like cleaners, local media reported. Thus, rapid and accurate confirmed diagnosis becomes urgent and pressing.

Learn from Chinese experience in fighting against the epidemic

With the sustaining deterioration of the epidemic in Brazil, the local museums and cultural centers have been closed in succession. Schools also suspend classes or reduce scheduled plans. Brazilian Ministry of Health suggests that large-scale activities shall be cancelled or put off in the whole country. The tourist entry to Brazil shall be in self-segregation for seven days. The public shall take personal protecting measures. Brazil Football (Confederacao Brasileira de Futebol) also declared that all national competitions shall be suspended.

▲Due to the global outbreak of COVID-19 cases, Brazilian airport staff wear gauze masks since being hit.

Presently, a number of Latin American Countries including Brazil are still in the rapid rising period of confirmed cases. The local media show great concern on Chinese anti-epidemic measures and effect. On March 12 the local time, the news spokesman of Chinese embassy to Brazil, interviewed live by Rede Golobo at 10 p.m. Evening News, introduced the Chinese anti-epidemic achievements in preventing and controlling novel COVID-19 pneumonia as well as the strategies of overall promoting epidemic fighting, economic and social development. Moreover, the spokesman also communicated with the interviewer in terms of Chinese epidemic-fighting and diagnosing experience, vaccine research and development, and the epidemic-fighting cooperation between China and Brazil.

Development Prospect of Jusha Medical

Jusha Medical is a global medical high-tech enterprise founded in 1996. The headquarters is located in Nanjing, PRC. Its high-tech industrial park is situated in Nanjing Jiangbei New Area. It governs two wholly-owned companies (each managing one wholly-owned subsidiary) and one holding company. Jusha Medical mainly engages in the R&D, production and sales of high-end medical digital X-ray equipment, overall solution for medical digital visualization, medical naked eye 3D display system, overall solution of intelligent operating room, high pressure injector and the products of infection-controlling cleaning, package and sterilization monitoring.

Since 2010, Jusha Medical has been making an overall arrangement of the transformation dominated by research and development. Presently, it has three R&D centers in Nanjing, Shanghai and Shenzhen, as well as the united R&D Department in Leeds, UK. Jusha Medical possesses the high-end R&D team, accounting for 30% of the total company staff. This is also the high-tech talent team with the top R&D strength in the domestic professional field. The annual investment in R&D accounts for 15% of the whole annual turnover. Presently, more than 800 domestic and international proprietary patents have been approved. Among them, many patents including “A Way Automatically Identifying and Calibrating Medical Colors and Gray Scale Images”, “An Effective Way Controlling the Highlighted Area Display of Console Display” and “Biological Indicator of Genetic Engineering” fill the gap of professional fields, which solved the issues perplexing the medical circles for many years.

▲ Jusha Medical and Leeds Medical Pathology Center, UK jointly founded a R&D institution overseas.

▲ The largest group hospital in Europe, Nottingham Hospital in UK, uses Jusha Medical 6M high-end display system for diagnosis.

Jusha Medical has set up numerous offices and after-sales service points globally. Its products and solutions have been applied for more than 70 countries and districts in the world, serving one billion patients globally for diagnosis and treatment. In recent years, Jusha Medical has increased its investment of R&D in the fields of medical image cloud platform, operating assistant robots, large-scale radiation equipment, infection control biological monitoring as well as the electronic monitoring interpretation. Magnificent achievements have been realized. Not only can it create value for the global customers, but also make its unique and valuable contributions to the human health undertaking.

▲Jusha Medical has developed as a global medical technological company integrating R&D, production and sales.

Confronting with the situation global fighting against novel COVID-19 pneumonia, Jusha Medical image terminal display system, by means of its accuracy, intelligence and efficient development, play the important supporting role in image diagnosis field, directly influencing the accuracy of novel COVID-19 pneumonia image diagnosis. Jusha Medical actively provides professional medical high-definition display system service for the global medical institutions, and makes its unique and valuable contributions to the auxiliary diagnosis of novel COVID-19 pneumonia by means of advanced scientific & technological means. This also embodies the promise of “Making Medical Diagnosis More Convenient and Intelligent, Making Operations Safer and More Efficient” advocated by Jusha Medical all the time.